[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100277897":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":17,"responsibleParty":35,"collaborators":7,"id":37,"slug":7,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":42,"eligibilityCriteria":43,"healthyVolunteers":38,"sex":44,"minAge":7,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":7,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"University Hospital, Brest","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Jean-Christophe Ianotto","CHRU de Brest","STUDY_DIRECTOR",[14],{"name":10,"role":15,"phone":7,"phoneExt":7,"email":16},"CONTACT","jean-christophe.Ianotto@chu-brest.fr",[18],{"facility":11,"status":19,"city":20,"state":7,"zip":21,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"RECRUITING","Brest","29609","France","FR",{"type":25,"coordinates":26},"Point",[27,28],-4.48628,48.39029,{"lat":28,"lon":27},[31,33],{"name":32,"role":15,"phone":7,"phoneExt":7,"email":7},"Jean-Christophe Ianotto, MD",{"name":34,"role":15,"phone":7,"phoneExt":7,"email":7},"Eric Lippert, MD-PhD",{"type":36,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100277897",false,"NCT02897297","Myeloproliferative Neoplastic Diseases Observatory From Brest","Observatoire Brestois Des Néoplasies Myéloprolifératives","OBENE","Inclusion Criteria:\n\n* Patients with essentiel thrombocythemia, polycythemia vera or primary myelofibrosis\n* Signature of the non-opposition consent form\n\nExclusion Criteria:\n\n* None","ALL",{"count":46,"type":47},1000,"ESTIMATED","OBSERVATIONAL","All patients diagnosed or followed in Brest University Hospital for Philadelphia negative myeloproliferative neoplasms will be included in this observational study.\n\nMyeloproliferative neoplasms recorded included: polycythemia vera, essential Thrombocythemia and Primary Myelofibrosis.\n\nThis is a not interventional study. Alive patients need to sign a non-opposition consent form.\n\nPatients will be followed until last news (death, change of reference centre...).",[51,52,53],"Polycythemia Vera","Essential Thrombocythemia","Primary Myelofibrosis","2024-08-09",{"date":56,"type":57},"2024-08-12","ACTUAL",{"date":59,"type":57},"2015-09-01",{"date":61,"type":47},"2025-09-30",{"name":5,"class":6},1]